Cargando…
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
The widespread use of primaquine (PQ) radical cure for P. vivax, is constrained by concerns over its safety. We used routinely collected patient data to compare the overall morbidity and mortality in patients treated with and without PQ without prior testing of Glucose-6-Phosphate-Dehydrogenase (G6P...
Autores principales: | Thriemer, Kamala, Poespoprodjo, Jeanne-Rini, Kenangalem, Enny, Douglas, Nicholas M., Sugiarto, Paulus, Anstey, Nicholas M., Simpson, Julie Anne, Price, Ric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657498/ https://www.ncbi.nlm.nih.gov/pubmed/33175835 http://dx.doi.org/10.1371/journal.pntd.0008838 |
Ejemplares similares
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019) -
Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017) -
High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019) -
Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
por: Douglas, Nicholas M, et al.
Publicado: (2014) -
Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2020)